Comparison of Patient- and Practitioner-Reported Toxic Effects Associated With Chemoradiotherapy for Head and Neck Cancer
Open Access
- 1 June 2016
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Otolaryngology–Head & Neck Surgery
- Vol. 142 (6) , 517-523
Abstract
Accurate assessment of toxic effects is an essential function in cancer clinical trials and routine care of cancer patients. In clinical trials, investigators commonly evaluate and quantify toxic effects and adverse events using the Common Terminology Criteria for Adverse Events (CTCAE) instrument developed by the National Cancer Institute.1 Emerging evidence suggests that direct patient reporting of symptoms may improve the accuracy and validity of toxic effects assessment.2 Disagreement between patient-reported and practitioner-reported symptomatic toxic effects has been extensively described3 and between-practitioner agreement in toxic effects ratings may also be only modest.4 There is evidence5,6 to suggest that, compared with practitioner reporting, patient-reported symptoms are more strongly correlated with clinical outcomes.Keywords
This publication has 25 references indexed in Scilit:
- Comparison Between Patient-Reported and Clinician-Observed Symptoms in OncologyCancer Nursing, 2013
- A prospective study of the feasibility and acceptability of a Web-based, electronic patient-reported outcome system in assessing patient recovery after major gynecologic cancer surgeryGynecologic Oncology, 2012
- The Effect of Treating Institution on Outcomes in Head and Neck CancerOtolaryngology–Head and Neck Surgery, 2012
- Patient Self-Reports of Symptoms and Clinician Ratings as Predictors of Overall Cancer SurvivalJNCI: Journal of the National Cancer Institute, 2011
- Reliability of adverse symptom event reporting by cliniciansQuality of Life Research, 2011
- Stakeholder perspectives on implementing the National Cancer Institute’s patient-reported outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)Translational Behavioral Medicine, 2011
- Adverse Symptom Event Reporting by Patients vs Clinicians: Relationships With Clinical OutcomesJNCI: Journal of the National Cancer Institute, 2009
- Evaluation of a mobile phone-based, advanced symptom management system (ASyMS©) in the management of chemotherapy-related toxicitySupportive Care in Cancer, 2008
- Factors Associated With Severe Late Toxicity After Concurrent Chemoradiation for Locally Advanced Head and Neck Cancer: An RTOG AnalysisJournal of Clinical Oncology, 2008
- CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatmentSeminars in Radiation Oncology, 2003